Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator.

Heart rhythm O2（2023）

引用 2|浏览51

暂无评分

摘要

The MODULAR ATP global clinical trial will prospectively test the safety and efficacy of the first intercommunicating leadless pacing system with the S-ICD. This trial will allow for robust validation of device-device communication, pacing performance, rate responsiveness, and system safety.

查看译文

关键词

Leadless pacemaker,Subcutaneous ICD,Defibrillator,Transcatheter pacemaker,Antitachycardia pacing

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要